Sresan Pharma Owner Arrested in Coldrif Case

By BPN News Desk October 9, 2025

Law & Order National

G. Ranganathan, the owner of Sresan Pharmaceuticals, has been arrested in Chennai over the deaths of children linked to the consumption of Coldrif cough syrup. Authorities confirmed that the arrest followed evidence of toxic contamination in the medicine. Toxic Contamination Found Laboratory

International

Europe Hit Hard by US Pharma Tariffs, India Safe

By BPN News Desk September 27, 2025

From October 1, 2025, the U.S. will impose 100% tariffs on imported branded or patented pharmaceutical products, unless the manufacturers are already building or expanding U.S. facilities. Who Is Most Exposed European pharmaceutical exporters are expected to be the worst affected, especially those exporting high-value branded drugs. India, by contrast, may be less impacted

International

Trump Announces Tariffs on Drugs, Furniture & More

By BPN News Desk September 26, 2025

U.S. President Donald Trump has announced new tariffs set to take effect on October 1, 2025. The proposed duties include 100% tariff on branded and patented pharmaceutical imports, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture, and 25% on heavy-duty trucks. Conditions and Exemptions Trump stated that pharmaceutical companies building

International

India Seeks New Markets for Pharma as U.S. Tariff Risks Grow

By BPN News Desk September 2, 2025

India is looking to expand its pharmaceutical exports to Russia, Brazil, and the Netherlands as a safeguard against possible U.S. tariff measures. The U.S. remains India’s largest market, accounting for nearly US$10.5 billion in exports in fiscal 2025, but growing trade tensions have pushed New Delhi to diversify its export destinations. Export Numbers and Growth […]

International

Trump Warns Pharma Firms to Cut Drug Prices or Face Action

By BPN News Desk August 1, 2025

U.S. President Donald Trump has issued formal public letters to 17 major pharmaceutical companies demanding that they reduce prescription drug prices in the United States within 60 days. He warned of serious consequences if the companies fail to comply by September 29. Trump’s Five Demands to Pharma In the letters, Trump laid out five specific […]